Navigation Links
3.0x SheerVision Loupes - SV Sport Frame

Products3.0x SheerVision Loupes - SV Sport Frame
Company SheerVision
Item 3.0x SheerVision Loupes - SV Sport Frame
Features 
  • Sharp, edge-to-edge clarity
  • High resolution optics
  • Lightweight design
  • Multi-coated for: anti-glare, anti-fog and scratch-resistance
  • Manufacturer direct pricing - save up to 40% off the competition
  • 30 day trial period
  • 100% satisfaction guaranteed
Description Experience the finest surgical-quality loupes available at manufacturer-direct prices. We set the standard for innovative optical design, combining superior quality withunmatched customer support. Delivering optimum performance with maximum comfort, SheerVision loupes are the clear choice for medical professionals worldwide. Make both a professional and a fashion statement by wearing the SV Sports Frame. The SV Sport Frame is available in eight vibrant colors and is designed so that prescription lenses can be added.
Info SheerVision
Customer Service: (877) 678-4274

Related medicine products :

1. SheerVision Surgical Magnifying Loupes
2. SheerVision FireFly LED Light System
3. FireFly LED Light System & SheerVision 2.5x Titanium-Frame Loupe Package
4. 3.0xx SheerVision Ultra-Light TTL Loupes - Titanium Frame
5. 2.5xx SheerVision Ultra-Light Loupes - SV Sport Frame
6. 3.0xx SheerVision Ultra-Light TTL Loupes - SV Sport Frame
7. 3.0x SheerVision Loupes - Titanium Frame
8. 3.0xx SheerVision Ultra-Light Loupes - SV Sport Frame
9. 3.5x SheerVision Loupes - SV Sport Frame
10. 3.0xx SheerVision Ultra-Light Loupes - Titanium Frame
11. 3.5x SheerVision Loupes - Titanium Frame
FlexWear is a cross-linked hydrocolloid skin barrier that provides aggressive adherence and is designed for more than one day weartime.
Inquire
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies. Security and confidence assured with internal no
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies with the added benefit of it being discreet in bo
Medicine Products:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...surgeons and haematologists at a hospital here hav...n the hearts of two patients, Spanish news agency ...ry unit at La Princesa University Hospital, said t...e bone marrow of the patients at the time of surge...
...is the first to use a particular cell model that m... spread of cancer. Using this model she identified... move out of the breast. As it is not possible to...ammary gland, we developed a model of the breast u...
...y has emphasised the safety and efficacy of Enbrel...toid arthritis (RA) patients . Biologics, such as...rally occurring protein in the body called tumour ...causing inflammation. When combined with methotrex...
...y has found that lizard mothers dress their childr...success under the conditions that the babies will ... California, Santa Cruz, have found that female si...uce different colour patterns in their broods in r...
Other Medicine News:Health News:Study Reinforces Safety of Long-term Biologic Treatment for Rheumatoid Arthritis 2Health News:Lizard Mothers Dress Their Progeny to Ensure Success in Later Life 2Health News:Lizard Mothers Dress Their Progeny to Ensure Success in Later Life 3
(Date:9/3/2008)... Company to Discuss Phase 3 Plans with...ile Therapeutics, Inc.,announced today that it su...e development of the company,s new, innovative low... company refers to by its internal product,code AG...ccessfully met its,primary endpoint of ovulation s...
(Date:9/3/2008)... SB-509 to be Evaluated in Repeat-Dosing Study in ...ewswire-FirstCall/ -- Sangamo,BioSciences, Inc. (N...a Phase,2 clinical trial (SB-509-801) to evaluate ...ive, degenerative motor-neuron disease for which t...Sangamo,s drug, SB-509, is an injectable formulati...
(Date:9/2/2008)...PARIS, September 3 /-, - T...ecreased the Risk,of Stroke by 34% in Patients Wit...equately Treated by Antithrombotic Therapy, The r... ATHENA study,were presented today at the clinical...ardiology congress 2008, in Munich, Germany. Previ...
(Date:9/2/2008)...HARRISBURG, Pa., Sept. 2 /PRNewswire-USNewswire/ -...ild animals is underway in western,Pennsylvania, A...e oral rabies vaccination baiting program covers a...r, Crawford, Erie, Fayette, Greene,Indiana, Lawre...counties., "Controlling the spread of rabies in w...
Breaking Medicine Technology:Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Rabies Vaccination Program Underway in Western Pennsylvania 2DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 1DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 2DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 3DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 4DHHS Guidelines Support Use of Trofile 28TM 29 Assay Prior to CCR5 Inhibitor Use 1303 52007 Another Record Year in Terms of Sales and Earnings for Gerresheimer 2952 12007 Another Record Year in Terms of Sales and Earnings for Gerresheimer 2952 22007 Another Record Year in Terms of Sales and Earnings for Gerresheimer 2952 3Smart holograms help patients help themselves 2104 1Smart holograms help patients help themselves 2104 2American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 1American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 2American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 3American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 10816 4
...2007 /PRNewswire-FirstCall/ -- Boston,Scientific C...ticle,in the Journal of of Cardiology (JACC) revie...es the Company,s second-generation,TAXUS(R) Libert...cle in the April 24 edition of JACC concluded that... of the TAXUS Liberte Stent,system compared to the...
...ata Presented at ASCO -, CHICAGO, June 04, 2007 /P...ay that Soliris(TM) (eculizumab), a new treatment ...loped by Alexion,Pharmaceuticals, Inc. , is effect...ory of aplastic anemia (AA) or myelodysplastic,syn...ood cell,destruction (hemolysis), decreased or eli...
Other Medicine Technology:Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 2Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 3Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 2Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 3Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 4Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 5Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 6Soliris Effective in PNH Patients With History of Aplastic Anemia,and Myelodysplastic Syndromes 7